Melina Higgins
Chairman at GENWORTH FINANCIAL, INC.
Net worth: 2 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| JoEllen Dillon | F | 60 |
Mylan NV
 Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 10 years |
| Richard Mark | M | 70 |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 4 years |
| Harry Korman | M | 66 |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 4 years |
| Ramsey Smith | M | 56 | 13 years | |
| Thomas McInerney | M | 67 | 11 years | |
| Melissa Trombetta | F | - |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 4 years |
| Jill Goodman | F | 57 | 3 years | |
| Gregory Karawan | M | 60 | 16 years | |
| Scott Smith | M | 61 | 2 years | |
| G. Conrad | M | 76 | 11 years | |
| Sheara Fredman | F | 49 | 22 years | |
| Karen Dyson | F | 64 | 4 years | |
| Jerome Upton | M | 60 | 14 years | |
| Howard Mills | M | 59 | 3 years | |
| Bill Szablewski | M | - | 4 years | |
| Marcie McClintic Coates | F | - | - | |
| Andrea White | F | 58 | 9 years | |
| Kelly Saltzgaber | M | 60 | - | |
| Burt Park | M | - | - | |
| Abhijit Barve | M | - |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | - |
| Mark Parrish | M | 68 | 4 years | |
| Darren Woodell | M | 48 | 14 years | |
| Janis Jones | F | 75 |
Women's Leadership Board
John F. Kennedy School
| - |
| Diane Nordin | F | 65 |
Antares Midco, Inc.
Antares Unitholder Investment LLC
 Antares Unitholder Investment LLC Financial ConglomeratesFinance Antares Unitholder Investment LLC provides middle market capital loan services. The company is headquartered in Chicago, IL. | - |
| Bob Restrepo | M | 73 | 8 years | |
| Leo Groothuis | M | - | 1 years | |
| Robert Coury | M | 63 | 4 years | |
| James Kilts | M | 76 | 4 years | |
| Anthony Mauro | M | 51 |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 4 years |
| Elaine Sarsynski | F | 68 | 2 years | |
| Rajiv Malik | M | 63 | 4 years | |
| Lakshmi Niwas Mittal | M | 72 | 16 years | |
| Wyllie Cornwell | M | 76 | 4 years | |
| Andrew Enrietti | M | - | - | |
| Lara Ramsburg | F | - | - | |
| Melissa Hagerman | F | 57 | 10 years | |
| Tanya Baker | F | - | 16 years | |
| Arun Narayan | M | 53 | - | |
| Ramkumar V. Rayapureddy | M | - | - | |
| Michael J. McCullough | M | 53 | 2 years | |
| Mark Hodges | M | 44 | 9 years | |
| Jamala Arland | F | 42 | 19 years | |
| Amy Rein | F | - | 3 years | |
| Anil Amin | M | - | - | |
| Mohammad Khalaf Mohammad Al-Tal | M | 84 |
John F. Kennedy School
| - |
| Jennifer Mauer | F | - | - | |
| Kristin DiBartolomeo | F | - | - | |
| Lydie Hudson | F | 45 |
Women's Leadership Board
| - |
| Beth Jacobs | F | - |
Women's Leadership Board
| - |
| Carol Hamilton | F | 71 |
Women's Leadership Board
| - |
| Patricia A. Wilmot | F | 74 |
Women's Leadership Board
| - |
| Ellen Kathrine Dyvik | F | - |
John F. Kennedy School
| - |
| Ellyn Shook | F | 61 |
Women's Leadership Board
| - |
| Dionysia L. Johnson-Massie | F | - |
Women's Leadership Board
| - |
| Beth Brooke | F | 64 |
Women's Leadership Board
| - |
| Anne Nobles | M | 67 |
Women's Leadership Board
| - |
| Peter L. Malkin | M | 90 |
John F. Kennedy School
| - |
| Gisselle Acevedo | F | 66 |
Women's Leadership Board
| - |
| Paula Madoff | F | 56 |
Women's Leadership Board
| - |
| Mohammed Al-Ardhi | M | - |
John F. Kennedy School
| - |
| Gideon Argov | M | 67 |
John F. Kennedy School
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Thain | M | 69 | 10 years | |
| John Thornton | M | 70 | 23 years | |
| Marty Klein | M | 64 | 4 years | |
| Randy Cowen | M | 73 | 26 years | |
| Ramon Chavez Márquez | M | 60 | 14 years | |
| Pauline van der Meer Mohr | F | 64 |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | - |
| Patrick Brian Kelleher | M | - | 6 years | |
| Kanad Singh Virk | M | 57 | 10 years | |
| James Sellers Riepe | M | 80 | 15 years | |
| Sheila Harilal Patel | F | - | 18 years | |
| Daniel Sheehan | M | 58 | 14 years | |
| Harvey Schwartz | M | 60 | 14 years | |
| Lisa Gay | F | 61 | 20 years | |
| Linnea Conrad Roberts | F | - | - | |
| Kevin D. Schneider | M | 62 | 13 years | |
| Michael Goettler | M | 56 | 3 years | |
| Robin Vince | M | 52 | 14 years | |
| Dan Jester | M | - | 18 years | |
| Amy R. Corbin | F | - | - | |
| Terry Travis | M | - | 13 years | |
| Robert Reffkin | M | 44 | 6 years | |
| Stephanie Bell-Rose | F | 66 | 10 years | |
| Jon Winkelried | M | 64 | 14 years | |
| Lois Juliber | F | 75 | 8 years | |
| James A. Parke | M | 78 | 14 years | |
| Alan M. Cohen | M | 73 | 13 years | |
| Dane Holmes | M | 53 | 12 years | |
| David Moffett | M | 72 | 9 years | |
| William George | M | 81 | 17 years | |
| Stephen Friedman | M | 86 | 8 years | |
| Henry M. Paulson | M | 77 | 8 years | |
| James J. Schiro | M | 78 | 5 years | |
| John Sheehan | M | 64 |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 6 years |
| William H. Bolinder | M | 80 | 9 years | |
| Wendy Cameron | F | 64 |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 16 years |
| Claes Dahlbäck | M | 76 | 12 years | |
| Sjoerd Steven Vollebregt | M | 69 |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | - |
| Steve Strongin | M | - | - | |
| Brian Curley | M | 54 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 97 | 97.00% |
| United Kingdom | 10 | 10.00% |
| Cayman Islands | 0 | -.--% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Melina Higgins
- Personal Network
